Results 1 to 13 of 13
  1. #1
    Veteran SpursforSix's Avatar
    My Team
    San Antonio Spurs
    Join Date
    Jul 2015
    Post Count
    18,889
    Surprised there's not a thread on this. The FDA advisory committee gave the Alzheimer's drug a pretty strong thumbs down but it gets approved anyway.
    No significant benefits with potential fatal side effects.

    Yet Biogen is going to charge $56,000 per year. Estimate cost to Medicare is over $57 billion.

    It's criminal.

    https://www.cnbc.com/2021/06/10/biog...ort-finds.html

  2. #2
    Mr. John Wayne CosmicCowboy's Avatar
    My Team
    San Antonio Spurs
    Join Date
    Mar 2003
    Post Count
    41,015
    It's not a done deal yet. It still has to go through phase 4 trial to actually prove clinical benefit. Proving it reduces the growth of plaque doesn't prove it actually benefits symptoms.

    One really ed up way that Medicare works, however is that it pays doctors 6% of the drug cost to prescribe it. That means they pay doctors $3,360 per year to prescribe it on top of the $56,000 cost.

  3. #3
    🏆🏆🏆🏆🏆 ElNono's Avatar
    My Team
    San Antonio Spurs
    Join Date
    Apr 2007
    Post Count
    143,728
    This is why Medicare needs to be empowered to negotiate drug prices, seeing they're by and large the largest customer.

  4. #4
    Savvy Veteran spurraider21's Avatar
    My Team
    San Antonio Spurs
    Join Date
    Apr 2012
    Post Count
    85,340
    This is why Medicare needs to be empowered to negotiate drug prices, seeing they're by and large the largest customer.
    but thats communist

    and also fascist at the same time

  5. #5
    🏆🏆🏆🏆🏆 ElNono's Avatar
    My Team
    San Antonio Spurs
    Join Date
    Apr 2007
    Post Count
    143,728
    but thats communist

    and also fascist at the same time
    Good ole American exceptionalism at work... lining up the pockets of the rich and powerful... in before CC's 'envy' post...

  6. #6
    4-25-20 Will Hunting's Avatar
    My Team
    Boston Celtics
    Join Date
    Jun 2009
    Post Count
    20,257
    Good ole American exceptionalism at work... lining up the pockets of the rich and powerful... in before CC's 'envy' post...
    Those lazy ass dementia patients need to just pull themselves up by their bootstraps and come up with the $50k needed for that experimental dementia treatment!

  7. #7
    🏆🏆🏆🏆🏆 ElNono's Avatar
    My Team
    San Antonio Spurs
    Join Date
    Apr 2007
    Post Count
    143,728
    Those lazy ass dementia patients need to just pull themselves up by their bootstraps and come up with the $50k needed for that experimental dementia treatment!
    Welfare queens!

  8. #8
    Savvy Veteran spurraider21's Avatar
    My Team
    San Antonio Spurs
    Join Date
    Apr 2012
    Post Count
    85,340
    Welfare queens!
    Thread is an expert on this subject

  9. #9
    notthewordsofonewhokneels Thread's Avatar
    My Team
    Los Angeles Lakers
    Join Date
    Mar 2010
    Post Count
    56,212
    Thread is an expert on this subject
    He offered it, 21. Then lied like a cheap rug from the Wal-Mart. Twixt me and the wife I'm out $1200. I'm grudgin' it, ever more.

  10. #10
    Believe.
    My Team
    San Antonio Spurs
    Join Date
    Jan 2007
    Post Count
    116
    Dale def needs this aduhelm asap.

  11. #11
    my unders, my frgn whites pgardn's Avatar
    My Team
    San Antonio Spurs
    Join Date
    Feb 2010
    Post Count
    32,415
    Bad move.
    Since 2006 there have been a number of drugs that have shown degradation of plaque and none showed improvement in symptoms. But there are some people who have seen significant improvement in symptoms as always in these types of drugs that get pushed. There is a really hard push on this one because the US has a large population of old people. People flat out live longer and this disease is mostly age related.

    And there are doctors who do NOT want to prescribe it (giving false hope) but what can they say now... lets give er a go for ~50K

  12. #12
    dangerous floater Winehole23's Avatar
    My Team
    San Antonio Spurs
    Join Date
    Nov 2008
    Post Count
    72,921
    how much is too much to pay for a marginally effective Alzheimer's drug with serious side effects?

    Before and after approval, there was speculation that this “potentially zillion-dollar moneymaker” (as Sharon Begley called itin October 2019) might bethe most lucrative drug ever. Last November it was notedthat if it brought in even a fraction of potential patients, it could still realistically be a $60 billion/year drug, changing Biogen’s revenue picture dramatically.


    Taking a high-side estimate of $110 billion/year, Nicholas Bagley and Rachel Sachs speculated in The Atlantic that Aduhelm could be the drug that breaks Medicare, given that that cost exceeds total current Part D medication expenses of $90 billion dollars.


    Even at a much lower total, Aduhelm’s costs would still balloon Medicare costs and would exceed the total NASA budget of $23 billion. Regardless of the exact total, the hit to Medicare would be big.
    https://hcrenewal.blogspot.com/2021/...ducanumab.html

  13. #13
    dangerous floater Winehole23's Avatar
    My Team
    San Antonio Spurs
    Join Date
    Nov 2008
    Post Count
    72,921
    from Scientific American in 2016

    one might well wonder how commonly journalists trade their integrity for access

    It was a faustian bargain—and it certainly made editors at National Public Radio squirm. The deal was this: NPR, along with a select group of media outlets, would get a briefing about an upcoming announcement by the U.S. Food and Drug Administration a day before anyone else. But in exchange for the scoop, NPR would have to abandon its reportorial independence. The FDA would dictate whom NPR’s reporter could and couldn’t interview….. NPR took the deal. “I’ll be at the briefing,” [NPR reporter Rob Stein] wrote… Later that day in April 2014, Stein—along with reporters from more than a dozen other top-tier media organizations, including CBS, NBC, CNN, the Washington Post, the Wall Street Journal and the New York Times—showed up at a federal building to get his reward. Every single journalist present had agreed not to ask any questions of sources not approved by the government until given the go-ahead.
    https://www.scientificamerican.com/article/how-the-fda-manipulates-the-media/

Thread Information

Users Browsing this Thread

There are currently 1 users browsing this thread. (0 members and 1 guests)

Posting Permissions

  • You may not post new threads
  • You may not post replies
  • You may not post attachments
  • You may not edit your posts
  •